Rupee Recoups Some Losses, After Weakening To A New Record Previously
The rupee recouped some losses early on Wednesday after having slid for the fifth consecutive day on Tuesday, during which it hit a fresh record low of 77.05, with investors still assessing the impact from the United States' and Britain's decision to ban Russian oil imports.
The Press Trust of India (PTI) reported on Wednesday the rupee advanced 22 paise to 76.78 against the US dollar, supported by the weakness in the American dollar and recovery in domestic equity markets.
Forex traders said the rupee could remain range-bound and can witness high volatility amid the deepening Russia-Ukraine conflict.
At the interbank foreign exchange, the rupee opened at 76.90 against the US dollar, then gained momentum and touched 76.78, registering a gain of 22 paise from the previous close.
The energy-sensitive rupee depreciated by 7 paise to close at a lifetime low of 77 against the US dollar on Tuesday, weighed by surging crude oil prices amid the Russia-Ukraine war.Â
According to PTI, the currency at the interbank forex market opened at 77.02 on Tuesday against the greenback and ranged between 76.71 and 77.05.
The rupee finally finished at 77.00, down 7 paise over its previous close of 76.93 against the greenback.
The surge in oil prices has directly correlated with the rupee's weakness on worries. The impact of that rise in energy costs would weigh on India's import bill, push up price pressures further and widen the trade deficit.
India imports nearly 80 per cent of its oil needs, and the purchasing power of the rupee dipping in international markets will hurt the overall economy and consumers.
Heavy foreign fund outflows and general risk aversion globally have also hurt the currency.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.